IMMULOGIC Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMMULOGIC

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Ira Vine who wrote (20)	4/3/1996 6:58:00 PM
From: Paul Getman	of 305

The rise in revenues was due to a milestone payment by HMR. Needless to say, there won't be any more of those any more, at least not from HRM. The best estimate I've seen for real revenues for IMUL is in 1998. The only thing I can really say about the Phase III trials for Allervax Cat is that the Phase II trials were designed more like a Phase III trial (placebo, double-blinded)and showed robust results. So the rigorous nature and the good results from the Phase II strongly suggest a favorable conclusion for the Phase III trial, but you never know! Paul

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next